To determine the intravitreal anti-vascular endothelial growth factor ( VEGF ) injection techniques and preferences within the retinal community and to identify potential factors associated with the development of sustained intraocular pressure ( IOP ) elevation in patients treated with intravitreal anti-VEGF therapy for neovascular age-related macular degeneration ( AMD ) .